\
&
Contact us
\
&
Contact us
Published on | 2 months ago
Programmes MSCAThere is 1 attachment connected to this article.
Attachments are only accessible for people with an account on the NCP Flanders website.
The evaluation results of the Marie Sklodowska-Curie Actions (MSCA) Doctoral Networks (DN) 2024 call (deadline 27 November 2024) were announced (see this article). A budget of €608.6 million is available. A total of 1417 proposals were submitted for the call, 1249 for Doctoral Networks standard, 80 for Industrial Doctorates and 88 for Joint Doctorates. 149 proposals were retained for funding, of which 133 for Doctoral Networks standard, 8 for Industrial Doctorates and 8 for Joint Doctorates. The success rate for this call is 10.9%. More information on the evaluation procedure can be found in the HE MSCA 2023-2025 work programme, under section 1.5 procedure (p. 114-117)
More information on the results of the call can be found in several resources published on the call topic page for HORIZON MSCA 2024 DN (under topic updates) on the European Commission Funding & Tender portal:
The proposals that were selected for funding with a coordinating organisation in Flanders can be found in the attached file.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Horizon Europe Digital Europe AI Continent
The Commission unveiled new features for artificial intelligence (AI) researchers and industry on itsAI-on-Demand platform, including an AI marketplace, an AI development tool that requires minimal coding, as well as secure solutions for generative AI and large language models. The platform, developed jointly by the EU-funded projects AI... read more
Health Digital, Industry & Space AI Continent Deployment: Best use of technologies
The European Commission has launched a procurement procedure for a Virtual Human Twins (VHT) Platform Project Support Office.The main goal of the Project Support Office (PSO) will be to provide support and advice to the Contracting Authority in managing the VHT Platform framework contract and specific contracts. The PSO will ensure h... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
